Reported covered position: US House of Representatives 1975 to 2015
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2026 · third_quarter · Q3
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2026 · third_quarter · Q3
Source: Senate LDA
| IMMIGRATION VOICE | 11 | 2020–2022 |
| RED OAK RESERVE, LLC | 9 | 2019–2021 |
| T-MOBILE USA, INC. | 6 | 2015–2021 |
| AMERICAN ASSOCIATION FOR JUSTICE | 5 | 2016 |
| CALIFORNIA STATE COUNCIL OF SERVICE EMPLOYEES | 5 | 2015 |
| JERRY JUNG | 4 | 2017–2019 |
| BRAEBURN INC. | 3 | 2018 |
| TRACFONE WIRELESS, INC. | 3 | 2016 |
| GREENTH, INC. | 1 | 2018 |
| MEDICINES360 | 1 | 2018 |
| TIOGA FUND | 1 | 2021 |
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
To prevent across-the-board direct spending cuts, and for other purposes.
Client: CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS · Firm: WAXMAN STRATEGIES
Reversing policies that harm CAPH and its members through support of H.R.1868 - To prevent across-the-board direct spending cuts, and for other purposes
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Proposed Internal Revenue Code Section 163(n) limit on deductions as part of the Build Back Better Act (HR 5376)
Fairness for High-Skilled Immigrants Act of 2020
Client: IMMIGRATION VOICE · Firm: WAXMAN STRATEGIES
Advocating for passage of H.R.1044 and S.386 - Fairness for High-Skilled Immigrants Act
Fairness for High-Skilled Immigrants Act of 2020
Client: IMMIGRATION VOICE · Firm: WAXMAN STRATEGIES
S 386/HR 1044, The Fairness for High Skilled Immigrants Act, a bill to end per country limits on green cards based on country of origin.
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Further Consolidated Appropriations Act, 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Further Consolidated Appropriations Act, 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Further Consolidated Appropriations Act, 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Further Consolidated Appropriations Act, 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Issues related to reforming and strengthening treatment of syndicated conservation easements (S170 and HR1992)
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Biodiesel Tax Credit Extension Act of 2019
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package
Biodiesel Tax Credit Extension Act of 2019
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package; Comments to the Select Committee on the Climate Crisis, including on Biofuels
Biodiesel Tax Credit Extension Act of 2019
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package
Biodiesel Tax Credit Extension Act of 2019
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package; Comments to the Select Committee on the Climate Crisis, including on biofuels
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
GREENER Fuels Act
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package
GREENER Fuels Act
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package
GREENER Fuels Act
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package; Comments to the Select Committee on the Climate Crisis, including on biofuels
GREENER Fuels Act
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package; Comments to the Select Committee on the Climate Crisis, including on Biofuels
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Issues related to reforming and strengthening treatment of syndicated conservation easements (S170 and HR1992)
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Prescription Drug Pricing Reduction Act of 2019
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Prescription Drug Pricing Reduction Act of 2019
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Prescription Drug Pricing Reduction Act of 2019
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
Prescription Drug Pricing Reduction Act of 2019
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act; S. 2543 - The Prescription Drug Pricing Reduction Act.
GREENER Fuels Act
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package; Comments to the Select Committee on the Climate Crisis, including on Biofuels
GREENER Fuels Act
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package
GREENER Fuels Act
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package
GREENER Fuels Act
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package; Comments to the Select Committee on the Climate Crisis, including on biofuels
Fairness for High-Skilled Immigrants Act of 2019
Client: IMMIGRATION VOICE · Firm: WAXMAN STRATEGIES
S 386/HR 1044, The Fairness for High Skilled Immigrants Act, a bill to end per country limits on green cards based on country of origin.
Fairness for High-Skilled Immigrants Act of 2019
Client: IMMIGRATION VOICE · Firm: WAXMAN STRATEGIES
Advocating for passage of H.R.1044 and S.386 - Fairness for High-Skilled Immigrants Act
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act.
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Orange Book Transparency Act of 2020
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Further Extension of Continuing Appropriations Act, 2021
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Further Consolidated Appropriations Act, 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Charitable Conservation Easement Program Integrity Act of 2019
Client: RED OAK RESERVE, LLC · Firm: WAXMAN STRATEGIES
Seeking changes to S. 170 and Hr 1992, The Charitable Conservation Easement Integrity Act
Biodiesel Tax Credit Extension Act of 2019
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation
Biodiesel Tax Credit Extension Act of 2019
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation
Biodiesel Tax Credit Extension Act of 2019
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package; Comments to the Select Committee on the Climate Crisis
Seeking pro environment reforms to the renewable fuel standard; seeking to minimize taxpayer subsidies for unsustainable biodiesel; Biodiesel Tax Credit Extension Act of 2019 HR 2089 and S617
Seeking pro environment reforms to the renewable fuel standard; seeking to minimize taxpayer subsidies for unsustainable biodiesel; Biodiesel Tax Credit Extension Act of 2019 HR 2089 and S617
Biodiesel Tax Credit Extension Act of 2019
Client: EUROPEAN FEDERATION FOR TRANSPORT AND ENVIRONMENT · Firm: WAXMAN STRATEGIES
HR 2089 Biodiesel Tax Credit; Education around no imported deforestation legislation; Greener Fuels Act HR 5113, S 2873; Energy tax extenders package; Comments to the Select Committee on the Climate Crisis
Seeking pro environment reforms to the renewable fuel standard; seeking to minimize taxpayer subsidies for unsustainable biodiesel; Biodiesel Tax Credit Extension Act of 2019 HR 2089 and S617
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act.
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Prescription Drug STAR Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act.
Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
Client: CAMPAIGN FOR TOBACCO FREE KIDS · Firm: WAXMAN STRATEGIES
H.R. 2339, HR 1865 - Issues related to tobacco, e-cigarettes and public health.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GARY AND MARY WEST HEALTH INSTITUTE, INC · Firm: WAXMAN STRATEGIES
Issues impacting drug prices; H.R. 1503 - Orange Book Transparency Act; H.R. 1520 - Purple Book Continuity Act of 2019; H.R. 2113 - Prescription Drug STAR Act; H.R 3 - Lower Drug Costs Now Act.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; appropriations for 340B program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2026 · first_quarter · 1T
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2026 · second_quarter · Q2
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2026 · second_quarter · Q2
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; appropriations for 340B program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2026 · first_quarter · Q1
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2026 · first_quarter · 1A
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; appropriations for 340B program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2026 · first_quarter · Q1
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2026 · first_quarter · Q1
Issues affecting the 340B drug pricing program, drug prices, and health care costs
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2025 · fourth_quarter · Q4
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2025 · fourth_quarter · Q4
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2025 · fourth_quarter · Q4
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2025 · third_quarter · Q3
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2025 · third_quarter · Q3
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2025 · third_quarter · Q3
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2025 · second_quarter · Q2
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2025 · second_quarter · Q2
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2025 · second_quarter · Q2
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2025 · first_quarter · Q1
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2025 · first_quarter · Q1
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2025 · first_quarter · Q1
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2024 · fourth_quarter · Q4
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2024 · fourth_quarter · Q4
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2024 · fourth_quarter · Q4
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2024 · third_quarter · Q3
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2024 · third_quarter · Q3
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2024 · third_quarter · Q3
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2024 · second_quarter · Q2
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2024 · second_quarter · Q2
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2024 · second_quarter · Q2
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2024 · first_quarter · Q1
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2024 · first_quarter · Q1
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2024 · first_quarter · Q1
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2023 · fourth_quarter · Q4
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2023 · fourth_quarter · Q4
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2023 · fourth_quarter · Q4
Issues related to Medicaid DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2023 · fourth_quarter · Q4
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2023 · third_quarter · Q3
Issues related to Medicaid DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2023 · third_quarter · Q3
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2023 · third_quarter · Q3
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2023 · third_quarter · Q3
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2023 · second_quarter · Q2
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2023 · second_quarter · Q2
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2023 · second_quarter · Q2
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2023 · first_quarter · 1T
Issues related to Medicaid DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2023 · first_quarter · Q1
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2023 · first_quarter · Q1
Issues impacting drug prices and health care costs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2023 · first_quarter · Q1
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via WAXMAN STRATEGIES
2023 · first_quarter · 1T
COVID response legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMIGRATION VOICE via WAXMAN STRATEGIES
2022 · fourth_quarter · 4T
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMIGRATION VOICE via WAXMAN STRATEGIES
2022 · fourth_quarter · Q4
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2022 · fourth_quarter · Q4
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2022 · fourth_quarter · Q4
Issues impacting drug prices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2022 · fourth_quarter · Q4
Issues related to Mediciad DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2022 · fourth_quarter · Q4
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via WAXMAN STRATEGIES
2022 · fourth_quarter · Q4
COVID response legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2022 · third_quarter · Q3
Issues related to Mediciad DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMIGRATION VOICE via WAXMAN STRATEGIES
2022 · third_quarter · Q3
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2022 · third_quarter · Q3
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2022 · third_quarter · Q3
Issues impacting drug prices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2022 · third_quarter · Q3
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via WAXMAN STRATEGIES
2022 · third_quarter · Q3
COVID response legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2022 · second_quarter · Q2
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2022 · second_quarter · Q2
Issues impacting drug prices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2022 · second_quarter · Q2
Issues related to Mediciad DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2022 · second_quarter · Q2
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via WAXMAN STRATEGIES
2022 · second_quarter · Q2
COVID response legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMIGRATION VOICE via WAXMAN STRATEGIES
2022 · second_quarter · Q2
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2022 · first_quarter · 1A
Issues related to Mediciad DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2022 · first_quarter · Q1
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMIGRATION VOICE via WAXMAN STRATEGIES
2022 · first_quarter · Q1
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2022 · first_quarter · Q1
Issues impacting drug prices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2022 · first_quarter · Q1
Issues related to Mediciad DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2022 · first_quarter · Q1
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via WAXMAN STRATEGIES
2022 · first_quarter · Q1
COVID response legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RED OAK RESERVE, LLC via WAXMAN STRATEGIES
2021 · first_quarter · 1A
Issues related to reforming and strengthening treatment of syndicated conservation easements
Issues related to reforming and strengthening treatment of syndicated conservation easements
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
IMMIGRATION VOICE via WAXMAN STRATEGIES
2021 · fourth_quarter · Q4
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2021 · fourth_quarter · Q4
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2021 · fourth_quarter · Q4
Issues impacting drug prices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T-MOBILE USA, INC. via WAXMAN STRATEGIES
2021 · fourth_quarter · Q4
Proposed Internal Revenue Code Section 163(n) limit on deductions as part of the Build Back Better Act (HR 5376)
Filing targets: HOUSE OF REPRESENTATIVES
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2021 · fourth_quarter · Q4
Issues related to Mediciad DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2021 · fourth_quarter · Q4
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via WAXMAN STRATEGIES
2021 · fourth_quarter · Q4
COVID response legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMIGRATION VOICE via WAXMAN STRATEGIES
2021 · third_quarter · Q3
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2021 · third_quarter · Q3
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2021 · third_quarter · Q3
Issues impacting drug prices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2021 · third_quarter · Q3
Issues related to Mediciad DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2021 · third_quarter · Q3
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via WAXMAN STRATEGIES
2021 · third_quarter · Q3
COVID response legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIOGA FUND via WAXMAN STRATEGIES
2021 · third_quarter · RR
Generate awareness and support for legislative proposals that require the biggest polluters to pay into a climate fund
Generate awareness and support for legislative proposals that require the biggest polluters to pay into a climate fund
IMMIGRATION VOICE via WAXMAN STRATEGIES
2021 · second_quarter · Q2
Creating a fair and equitable, first come, first serve system for receiving employment-based green cards; H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2021 · second_quarter · Q2
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE, INC via WAXMAN STRATEGIES
2021 · second_quarter · Q2
Issues impacting drug prices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2021 · second_quarter · Q2
Issues related to Mediciad DSH payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2021 · second_quarter · Q2
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via WAXMAN STRATEGIES
2021 · second_quarter · Q2
COVID response legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2021 · first_quarter · 1A
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via WAXMAN STRATEGIES
2021 · first_quarter · 1A
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Issues affecting the 340B drug pricing program; Appropriations for 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA ASSOCIATION OF PUBLIC HOSPITALS AND HEALTH SYSTEMS via WAXMAN STRATEGIES
2021 · first_quarter · Q1
Reversing policies that harm CAPH and its members through support of H.R.1868 - To prevent across-the-board direct spending cuts, and for other purposes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMPAIGN FOR TOBACCO FREE KIDS via WAXMAN STRATEGIES
2021 · first_quarter · Q1
Issues related to tobacco, e-cigarettes and public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE